Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX).
- Disclosed ownership: 4.4%.
- Date of event: 15 Oct 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 4.4% ownership in Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX) on 15 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.3% | 635,200 | 0 | 635,200 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.3% | 635,200 | 0 | 635,200 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.7% | 461,474 | 0 | 461,474 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.7% | 461,474 | 0 | 461,474 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 73,866 | 0 | 73,866 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 73,866 | 0 | 73,866 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 4% | 1,096,674 | 0 | 1,096,674 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 4.4% | 1,189,165 | 0 | 1,189,165 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 4.4% | 1,189,165 | 0 | 1,189,165 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 4.4% | 1,189,165 | 0 | 1,189,165 | /s/ Mark N. Lampert | Mark N. Lampert |